0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Cardiovascular medicine

Buy Now

Cardiac Fibrosis and Heart Failure: Cause or Effect? (Hardcover, 2015 ed.) Loot Price: R4,936
Discovery Miles 49 360
Cardiac Fibrosis and Heart Failure: Cause or Effect? (Hardcover, 2015 ed.): Ian M.C. Dixon, Jeffrey T. Wigle

Cardiac Fibrosis and Heart Failure: Cause or Effect? (Hardcover, 2015 ed.)

Ian M.C. Dixon, Jeffrey T. Wigle

Series: Advances in Biochemistry in Health and Disease, 13

 (sign in to rate)
Loot Price R4,936 Discovery Miles 49 360 | Repayment Terms: R463 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

The unique biology of cardiac fibroblasts and related cells, such as cardiac myofibroblasts and valvular interstitial cells, distinguish them from other fibroblastic cells, a concept that is only beginning to be widely appreciated. Further, the natural signals that stimulate and inhibit cardiac fibrosis within these cells are not well understood. This volume compiles articles that address the molecular mechanisms that control the synthesis and secretion of the cardiac ECM. The book showcases chapters that highlight discussion of role of Transforming Growth Factor (TGF ), an important fibrogenic cytokine and its downstream effectors SMAD in many cardiac diseases. Further, the contributions highlight information to discuss endogenous inhibitors of cardiac fibrosis, as well as advances in tissue engineering specific to matrix in the heart. Finally, discussions of unifying mechanisms of matrix remodeling in valves and myocardium are presented. The mechanisms involved in the stimulation of cardiac fibrosis are not fully understood. In most cases the marginal attenuation of cardiac fibrosis as a result of a given therapy is a beneficial side-effect linked to other primary effects on other cells, especially cardiomyocytes. Very few drugs or agents are known to affect the function and dysfunction of cardiac fibroblasts and myofibroblasts alone. The book helps to translate the information gathered within to allow us to alter the course of fibrogenic events that are typical of cardiac fibrosis, and thereby reduce their burden on the patient and on society itself.

General

Imprint: Springer International Publishing AG
Country of origin: Switzerland
Series: Advances in Biochemistry in Health and Disease, 13
Release date: July 2015
First published: 2015
Editors: Ian M.C. Dixon • Jeffrey T. Wigle
Dimensions: 235 x 155 x 25mm (L x W x T)
Format: Hardcover
Pages: 436
Edition: 2015 ed.
ISBN-13: 978-3-319-17436-5
Categories: Books > Medicine > Clinical & internal medicine > Cardiovascular medicine
Promotions
LSN: 3-319-17436-3
Barcode: 9783319174365

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners